US based Baxter started its global pharmaceuticals research and development (R&D) centre in Ahmedabad, India. This centre will also support Baxter's global manufacturing facilities, including those in Ahmedabad, Germany, Ireland, Italy, and the United States, among others.
The 20,500-square-foot, state-of-the-art R&D Centre houses sophisticated equipment and research labs that will focus on pharmaceutical product development and capabilities in therapeutic areas such critical care, analgesic, renal, cardiovascular anesthesia, anti-infective and antipyretic.
The R&D Centre is part of Baxter’s network of more than 25 global R&D centers, including 4 in the Asia-Pacific region.
"Our world-class Ahmedabad R&D Centre is critical to unleashing the full power of our Pharmaceuticals pipeline and helping us advance patient care worldwide through differentiated injectable products to be commercialized globally," said Alok Sonig, president, Pharmaceuticals, Baxter International.
"Our team in India, particularly those working in the Ahmedabad Pharmaceuticals R&D Centre, will play an integral role in advancing our pipeline, expanding our products to new markets and innovating to continue responding to the needs of patients all over the world," said Mahesh Chaubal, vice president, Pharmaceuticals R&D, of Baxter International.
